John P. Hamill
2017 - Cellectar Biosciences
In 2017, John P. Hamill earned a total compensation of $169.8K as Interim Chief Financial Officer at Cellectar Biosciences.
Compensation breakdown
Other | $169,838 |
---|---|
Total | $169,838 |
Hamill received $169.8K in other compensation, accounting for 100% of the total pay in 2017.
Rankings
In 2017, John P. Hamill's compensation ranked 14,206th out of 14,666 executives tracked by ExecPay. In other words, Hamill earned more than 3.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 14,206 | 3rd |
Manufacturing | 5,587 | 3rd |
Chemicals And Allied Products | 2,008 | 3rd |
Drugs | 1,670 | 4th |
Pharmaceutical Preparations | 1,281 | 4th |
Hamill's colleagues
We found four more compensation records of executives who worked with John P. Hamill at Cellectar Biosciences in 2017.
News
Aprea Therapeutics CFO John Hamill's 2023 pay jumps 62% to $908K
April 25, 2024
Discovery Laboratories CEO Craig Fraser's 2022 pay falls 50% to $941K
June 29, 2023
Discovery Laboratories CEO Craig Fraser's 2021 pay jumps 144% to $1.9M
May 11, 2022
Discovery Laboratories COO Eric Curtis receives $1.8M in 2020
April 30, 2021
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019